Atrial Fibrillation (AF), Heart Failure
Conditions
Keywords
Medication adherence, MAI, BMQ, Atrial fibrillation, Heart failure, CCU, brief medication questionnaire, medication appropriateness index
Brief summary
This study aims to assess medication adherence and the appropriateness of prescribed medications among patients admitted to the Coronary Care Unit (CCU). The study will use the Medication Appropriateness Index (MAI) to evaluate the suitability of prescribed medications and the Beliefs about Medicines Questionnaire (BMQ) to assess patients' beliefs and perceptions regarding their medications. Understanding medication adherence and related beliefs may help identify factors associated with inappropriate medication use and non-adherence in hospitalized cardiac patients. The findings of this study may contribute to improving medication management and patient care in the CCU setting.
Detailed description
This is a cross-sectional observational study conducted in the Coronary Care Unit (CCU). The study evaluates medication adherence and the appropriateness of prescribed medications among hospitalized cardiac patients. Medication appropriateness is assessed using the Medication Appropriateness Index (MAI), and patients' beliefs about medicines are assessed using the Beliefs about Medicines Questionnaire (BMQ). Data are collected through medical record review and patient interviews during hospitalization. The study involves no intervention or modification of routine clinical care.
Interventions
OTHERNo intervention (observational study)
This is an observational study with no active intervention.
Sponsors
AlFayhaa General Hospital
Study design
Observational model
COHORT
Time perspective
CROSS_SECTIONAL
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Adult patients aged 18 years or older * Diagnosed with atrial fibrillation or heart failure * Admitted to the coronary care unit * Clinically stable at the time of interview * Able to provide informed consent
Exclusion criteria
* Significant cognitive impairment * Communication difficulties preventing interview * Diagnosed psychiatric disorder interfering with participation
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Medication adherence (BMQ) | During CCU admission after clinical stabilization (assessed up to 5 days) | Medication adherence will be assessed using the Brief Medication Questionnaire (BMQ), a validated tool that evaluates medication-taking behavior and barriers to adherence. |
| Medication appropriateness measured by Medication Appropriateness Index (MAI) | During CCU admission after clinical stabilization (assessed up to 5 days) | Medication appropriateness will be assessed using the Medication Appropriateness Index (MAI). The MAI score ranges from 0 to 12, where lower scores indicate better medication adherence and higher scores indicate poorer adherence. |
Countries
Iraq
Contacts
CONTACTSuror S Alsabbagh, Bachelor of Pharmacy
Outcome results
None listed